Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Baxter, S.W.
Right arrow Articles by Campbell, I.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baxter, S.W.
Right arrow Articles by Campbell, I.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 1, 63-66, January 2001
© 2001 Oxford University Press


CANCER BIOLOGY

GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer

S.W. Baxter1, E.J. Thomas2 and I.G. Campbell1,2,3

1 VBCRC Cancer Genetics Laboratory, Peter MacCallum Cancer Institute, Locked Bag No. 1 A'Beckett St., Victoria 8006, Australia and
2 Obstetrics and Gynaecology, University of Southampton, Princess Anne Hospital, Coxford Road, Southampton SO16 5YA, UK

It is likely that heritable genetic factors contribute to the development of endometriosis, which is a putative precursor of the endometrioid and clear cell histological subtypes of ovarian cancer. The phase II glutathione S-transferases (GSTs) are a family of enzymes responsible for metabolism of a broad range of xenobiotics and carcinogens. Allelic variants of GSTs that have impaired detoxification function may increase the rate of genetic damage and thereby increase the susceptibility to cancer. The null genetic polymorphism in the gene encoding the GST class µ (GSTM1) enzyme has been reported to be significantly elevated in endometriosis patients and may represent an endometriosis susceptibility allele. In this study the frequency of the GSTM1 null genotype was investigated in 84 cases of endometriosis, 293 cases of ovarian cancer and 219 controls. All cases and controls were derived from women resident in the south east of England. The frequency of the GSTM1 null allele was not over-represented in the endometriosis patients (47.6%) compared with the controls (48.9%) (P = 0.898). In the ovarian cancer group the GSTM1 null genotype was significantly elevated compared with controls (59.0 versus 48.9%, P = 0.025). When stratified according to histological subtype a significantly increased GSTM1 null genotype was only observed for the endometrioid (65.4%, P = 0.013) and the combined endometrioid/clear cell ovarian cancers (67.0%, P = 0.004). We conclude that the GSTM1 null allele is not an endometriosis susceptibility allele, however, it may predispose endometriotic lesions to malignant transformation to endometrioid and clear cell ovarian cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
In VivoHome page
P. G. SIGNORILE, M. CAMPIONI, B. VINCENZI, A. D'AVINO, and A. BALDI
Rectovaginal Septum Endometriosis: An Immunohistochemical Analysis of 62 Cases
In Vivo, May 1, 2009; 23(3): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. R. Hansson, B. Bottalico, V. Noskova, and B. Casslen
Monoamine transporters in human endometrium and decidua
Hum. Reprod. Update, March 1, 2009; 15(2): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C.B. Tempfer, M. Simoni, B. Destenaves, and B.C.J.M. Fauser
Functional genetic polymorphisms and female reproductive disorders: Part II--endometriosis
Hum. Reprod. Update, January 1, 2009; 15(1): 97 - 118.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Vigano, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini
Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis
Hum. Reprod. Update, January 1, 2006; 12(1): 77 - 89.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S.-W. Guo
Glutathione S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis of genetic association studies
Mol. Hum. Reprod., October 1, 2005; 11(10): 729 - 743.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. E. Hur, J. Y. Lee, H.-S. Moon, and H. W. Chung
Polymorphisms of the genes encoding the GSTM1, GSTT1 and GSTP1 in Korean women: no association with endometriosis
Mol. Hum. Reprod., January 1, 2005; 11(1): 15 - 19.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-C. Lin, J.-M. Chen, and C.-H. Tsai
Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis
Mol. Hum. Reprod., October 1, 2004; 10(10): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
D. Lattuada, P. Vigano, E. Somigliana, M. P. Odorizzi, M. Vignali, and A. M. Di Blasio
Androgen Receptor Gene Cytosine, Adenine, and Guanine Trinucleotide Repeats in Patients With Endometriosis
Reproductive Sciences, May 1, 2004; 11(4): 237 - 240.
[Abstract] [PDF]


Home page
ReproductionHome page
R. Varma, T. Rollason, J. K Gupta, and E. R Maher
Endometriosis and the neoplastic process
Reproduction, March 1, 2004; 127(3): 293 - 304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wu, X. Zhang, F. Bardag-Gorce, R. C. V. Robel, J. Aguilo, L. Chen, Y. Zeng, K. Hwang, S. W. French, S. C. Lu, et al.
Retinoid X Receptor {alpha} Regulates Glutathione Homeostasis and Xenobiotic Detoxification Processes in Mouse Liver
Mol. Pharmacol., March 1, 2004; 65(3): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P. Vigano, M. Infantino, D. Lattuada, R. Lauletta, E. Ponti, E. Somigliana, M. Vignali, and A.M. DiBlasio
Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis
Mol. Hum. Reprod., January 1, 2003; 9(1): 47 - 52.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. T. Zondervan, L. R. Cardon, and S. H. Kennedy
What makes a good case-control study?: Design issues for complex traits such as endometriosis
Hum. Reprod., June 1, 2002; 17(6): 1415 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R.M. Hadfield, S. Manek, D.E. Weeks, H.J. Mardon, D.H. Barlow, and S.H. Kennedy
Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1
Mol. Hum. Reprod., November 1, 2001; 7(11): 1073 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Nakago, R. M. Hadfield, K. T. Zondervan, H. Mardon, S. Manek, D. E. Weeks, D. Barlow, and S. Kennedy
Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population
Mol. Hum. Reprod., November 1, 2001; 7(11): 1079 - 1083.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.